Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Circadian Rhythm | 10 | 2024 | 305 | 3.440 |
Why?
|
| Endocannabinoids | 5 | 2024 | 31 | 3.290 |
Why?
|
| Glycerides | 4 | 2020 | 17 | 2.400 |
Why?
|
| Arachidonic Acids | 4 | 2020 | 41 | 2.390 |
Why?
|
| Sleep | 13 | 2024 | 452 | 2.090 |
Why?
|
| Obesity | 8 | 2024 | 971 | 1.560 |
Why?
|
| Diabetic Retinopathy | 4 | 2024 | 91 | 1.430 |
Why?
|
| Sleep Deprivation | 6 | 2016 | 138 | 1.260 |
Why?
|
| Eating | 7 | 2024 | 166 | 1.180 |
Why?
|
| Melatonin | 3 | 2024 | 50 | 1.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2024 | 1176 | 1.090 |
Why?
|
| Retinal Ganglion Cells | 2 | 2024 | 70 | 1.050 |
Why?
|
| Conditioning, Operant | 4 | 2010 | 71 | 0.880 |
Why?
|
| Actigraphy | 1 | 2023 | 59 | 0.870 |
Why?
|
| Reward | 6 | 2016 | 188 | 0.860 |
Why?
|
| C-Reactive Protein | 1 | 2023 | 192 | 0.820 |
Why?
|
| Motivation | 3 | 2013 | 296 | 0.590 |
Why?
|
| Inflammation | 1 | 2023 | 972 | 0.590 |
Why?
|
| Sleep Wake Disorders | 2 | 2023 | 117 | 0.550 |
Why?
|
| Nucleus Accumbens | 2 | 2010 | 113 | 0.550 |
Why?
|
| Hyperphagia | 1 | 2016 | 36 | 0.530 |
Why?
|
| Hydrocortisone | 4 | 2024 | 302 | 0.500 |
Why?
|
| Amphetamine | 2 | 2010 | 101 | 0.390 |
Why?
|
| Food | 1 | 2010 | 90 | 0.340 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2009 | 67 | 0.330 |
Why?
|
| Energy Metabolism | 2 | 2024 | 277 | 0.320 |
Why?
|
| Motor Skills | 1 | 2009 | 79 | 0.320 |
Why?
|
| Leptin | 3 | 2020 | 102 | 0.320 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 742 | 0.310 |
Why?
|
| Male | 15 | 2024 | 42372 | 0.310 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 2 | 2020 | 13 | 0.310 |
Why?
|
| Synapses | 1 | 2011 | 279 | 0.310 |
Why?
|
| Young Adult | 7 | 2021 | 6305 | 0.310 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 228 | 0.310 |
Why?
|
| Central Nervous System Stimulants | 1 | 2010 | 219 | 0.290 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2023 | 216 | 0.290 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 511 | 0.290 |
Why?
|
| Motor Cortex | 1 | 2009 | 199 | 0.280 |
Why?
|
| Cross-Over Studies | 2 | 2019 | 389 | 0.280 |
Why?
|
| Neuronal Plasticity | 1 | 2009 | 194 | 0.280 |
Why?
|
| Psychomotor Performance | 1 | 2009 | 496 | 0.260 |
Why?
|
| Body Weight | 2 | 2013 | 452 | 0.260 |
Why?
|
| Humans | 21 | 2024 | 89284 | 0.250 |
Why?
|
| Adult | 8 | 2024 | 26578 | 0.240 |
Why?
|
| Female | 10 | 2024 | 46154 | 0.230 |
Why?
|
| Muscimol | 1 | 2003 | 19 | 0.230 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2003 | 22 | 0.230 |
Why?
|
| GABA Agonists | 1 | 2003 | 20 | 0.230 |
Why?
|
| Rats | 6 | 2013 | 4041 | 0.220 |
Why?
|
| Lipoproteins, LDL | 1 | 2023 | 85 | 0.220 |
Why?
|
| Wakefulness | 2 | 2016 | 135 | 0.220 |
Why?
|
| Circadian Clocks | 2 | 2021 | 59 | 0.210 |
Why?
|
| Animals | 12 | 2024 | 27357 | 0.210 |
Why?
|
| Adolescent | 5 | 2021 | 9256 | 0.200 |
Why?
|
| Insulin Resistance | 2 | 2016 | 353 | 0.200 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2023 | 107 | 0.200 |
Why?
|
| Appetite Regulation | 2 | 2016 | 9 | 0.200 |
Why?
|
| Meals | 1 | 2021 | 22 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2013 | 1237 | 0.190 |
Why?
|
| Zinc | 1 | 2021 | 93 | 0.190 |
Why?
|
| Research Report | 1 | 2021 | 44 | 0.190 |
Why?
|
| Brain | 1 | 2011 | 2283 | 0.190 |
Why?
|
| Fasting | 3 | 2016 | 163 | 0.190 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 1714 | 0.190 |
Why?
|
| Gene Expression | 2 | 2019 | 1310 | 0.190 |
Why?
|
| Congresses as Topic | 1 | 2021 | 113 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2023 | 868 | 0.180 |
Why?
|
| Adie Syndrome | 1 | 2020 | 1 | 0.180 |
Why?
|
| Triiodothyronine | 1 | 2021 | 344 | 0.180 |
Why?
|
| Palmitic Acids | 1 | 2019 | 8 | 0.170 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2019 | 8 | 0.170 |
Why?
|
| Ethanolamines | 1 | 2019 | 24 | 0.170 |
Why?
|
| Amides | 1 | 2019 | 53 | 0.170 |
Why?
|
| Oleic Acids | 1 | 2019 | 26 | 0.170 |
Why?
|
| Analgesics, Opioid | 1 | 2003 | 444 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2021 | 187 | 0.160 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 282 | 0.160 |
Why?
|
| Middle Aged | 5 | 2024 | 25945 | 0.150 |
Why?
|
| Aged | 3 | 2024 | 19142 | 0.150 |
Why?
|
| Electroencephalography | 3 | 2011 | 750 | 0.140 |
Why?
|
| Adipose Tissue | 1 | 2019 | 259 | 0.140 |
Why?
|
| Hunger | 1 | 2016 | 23 | 0.130 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 146 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1858 | 0.130 |
Why?
|
| Ghrelin | 1 | 2015 | 29 | 0.120 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 506 | 0.120 |
Why?
|
| Insulin | 3 | 2015 | 1146 | 0.110 |
Why?
|
| Opioid Peptides | 1 | 2013 | 6 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1429 | 0.110 |
Why?
|
| Bariatric Surgery | 1 | 2016 | 195 | 0.110 |
Why?
|
| Neostriatum | 1 | 2013 | 26 | 0.110 |
Why?
|
| Thinness | 1 | 2012 | 44 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 51 | 0.090 |
Why?
|
| Behavior, Animal | 2 | 2011 | 378 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2013 | 727 | 0.090 |
Why?
|
| Reinforcement Schedule | 1 | 2010 | 17 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2013 | 327 | 0.090 |
Why?
|
| Dominance, Cerebral | 1 | 2009 | 66 | 0.080 |
Why?
|
| Rats, Long-Evans | 1 | 2009 | 49 | 0.080 |
Why?
|
| Models, Biological | 1 | 2016 | 1765 | 0.080 |
Why?
|
| Electromyography | 1 | 2009 | 193 | 0.080 |
Why?
|
| Dopamine | 1 | 2010 | 276 | 0.080 |
Why?
|
| Frontal Lobe | 1 | 2009 | 131 | 0.080 |
Why?
|
| Parietal Lobe | 1 | 2009 | 119 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 202 | 0.080 |
Why?
|
| Cerebral Cortex | 1 | 2011 | 589 | 0.070 |
Why?
|
| Brain Mapping | 1 | 2009 | 564 | 0.070 |
Why?
|
| Appetitive Behavior | 1 | 2005 | 15 | 0.060 |
Why?
|
| Disease Outbreaks | 1 | 2006 | 155 | 0.060 |
Why?
|
| Weight Loss | 1 | 2005 | 227 | 0.060 |
Why?
|
| Dopamine Agents | 1 | 2003 | 28 | 0.060 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2023 | 52 | 0.060 |
Why?
|
| Risk Factors | 2 | 2023 | 5493 | 0.050 |
Why?
|
| Health | 1 | 2021 | 29 | 0.050 |
Why?
|
| Publications | 1 | 2021 | 27 | 0.050 |
Why?
|
| Hormone Replacement Therapy | 1 | 2021 | 85 | 0.050 |
Why?
|
| Disease | 1 | 2021 | 90 | 0.050 |
Why?
|
| Reflex, Pupillary | 1 | 2020 | 8 | 0.040 |
Why?
|
| Mental Health | 1 | 2021 | 178 | 0.040 |
Why?
|
| Hypothyroidism | 1 | 2021 | 241 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 784 | 0.040 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2020 | 53 | 0.040 |
Why?
|
| Reference Standards | 1 | 2019 | 144 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1717 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2021 | 900 | 0.040 |
Why?
|
| Obesity, Morbid | 1 | 2019 | 233 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 15 | 0.030 |
Why?
|
| Endophenotypes | 1 | 2015 | 17 | 0.030 |
Why?
|
| Food Deprivation | 1 | 2015 | 24 | 0.030 |
Why?
|
| Age of Onset | 1 | 2015 | 312 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 711 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2880 | 0.030 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 123 | 0.030 |
Why?
|
| Enkephalins | 1 | 2013 | 16 | 0.030 |
Why?
|
| Neuropeptide Y | 1 | 2013 | 32 | 0.030 |
Why?
|
| Homeostasis | 1 | 2015 | 416 | 0.030 |
Why?
|
| Neuropharmacology | 1 | 2013 | 2 | 0.030 |
Why?
|
| Neuroanatomy | 1 | 2013 | 4 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2013 | 140 | 0.030 |
Why?
|
| Glucose | 1 | 2015 | 630 | 0.030 |
Why?
|
| Neuroimaging | 1 | 2013 | 117 | 0.030 |
Why?
|
| Rats, Inbred WKY | 1 | 2011 | 32 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2013 | 319 | 0.020 |
Why?
|
| Causality | 1 | 2009 | 80 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 3780 | 0.020 |
Why?
|
| Models, Neurological | 1 | 2011 | 411 | 0.020 |
Why?
|
| Action Potentials | 1 | 2011 | 600 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 5336 | 0.020 |
Why?
|
| Maternal Age | 1 | 2006 | 45 | 0.020 |
Why?
|
| Endocrine System | 1 | 2006 | 17 | 0.020 |
Why?
|
| Neoplasms | 1 | 2021 | 3038 | 0.020 |
Why?
|
| Temperature | 1 | 2006 | 401 | 0.020 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2006 | 203 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 4284 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 8232 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2006 | 773 | 0.010 |
Why?
|
| Prevalence | 1 | 2006 | 1243 | 0.010 |
Why?
|
| Smoking | 1 | 2006 | 621 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 2006 | 512 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2006 | 507 | 0.010 |
Why?
|
| Mice | 1 | 2015 | 11754 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 1868 | 0.010 |
Why?
|